Introduction
Worldwide, 35 million individuals are living with human immunodeficiency virus type 1 (HIV-1), including over 3.2 million children (≤15 years of age; CDC 2013). Despite the dramatic decrease in mother-to-child transmission (MTCT), the predominant source of HIV-1 infection in children (Kourtis et al. 2001) , 220,000 new cases of pediatric HIV-1 (PHIV) were reported in 2014 (UNAIDS 2015) . Since the advent of combination antiretroviral therapy (cART), PHIV has evolved from a fatal disease to a chronic disease as children perinatally infected with HIV-1 survive into adulthood (Smith and Wilkins 2015; Crowell et al. 2014) . Chronic neurological impairment is still commonly reported in children perinatally infected with PHIV despite the advancements resulting from cART (Franklin et al. 2005; Paramesparan et al. 2010) . Given the prevalence of PHIV, understanding early developmental alterations may provide an innovative clinical diagnostic screening tool for neurological impairment in HIV-1 seropositive children.
Progressive HIV-1 encephalopathy (PHE), which is often analogous to HIV-1 associated dementia (HAD) in adults, was predominantly observed prior to the advent of cART, with prevalence rates as high as 50 % (Chiriboga et al. 2005; Crowell et al. 2014; Shanbhag et al., 2005) . Common neurological manifestations of PHE include microcephaly (resulting from cerebral atrophy), developmental delays, and movement disorders (Belman et al. 1985; Epstein et al. 1985; Epstein et al. 1986 ). Furthermore, neuroimaging analyses revealed calcification in the basal ganglia, and focal white matter lesions in children with PHE (Epstein et al. 1985; Epstein et al. 1986; Kauffman et al. 1992) . Currently, in the post-cART era, the prevalence rate of PHE is between 2 and 15 % (Chiriboga et al. 2005; Shanbhag et al. 2005) .
High rates of chronic neurological impairment, including neurodevelopmental delays, continue to be reported in HIV-1 seropositive children (Franklin et al. 2005; Paramesparan et al. 2010; review, Van Rie et al. 2007 ). Neurological assessments, including the Bayley Scales of Infant Development and Wechsler Intelligence Scale for Children-Revised, have previously been used to assess the effect of pediatric HIV-1 on neurodevelopment (Blanchette et al. 2002; Lindsey et al. 2007; Van Rie et al. 2008; Walker et al. 2013) . Despite treatment with highly active antiretroviral therapy (HAART), HIV-1 infected children exhibit significant delays in cognitive development, motor skills and language expression in both high- (Lindsey et al. 2007 ) and low-resource countries (Van Rie et al. 2008; Walker et al. 2013) .
Neurocognitive deficits in HIV-1 seropositive children, including disease progression, are poorly understood (Crowell et al. 2014) , however, there is a relative wealth of knowledge on HIV-1 associated neurocognitive disorders (HAND) in adults evidenced in both clinical and preclinical studies (i.e. Heaton et al. 2010; review, Woods et al. 2009 ). Neurocognitive assessments, including the Wisconsin Card Sorting Test and Stroop Color Word Test, have shown that HIV-1 seropositive individuals display significant deficits in set shifting (Carter et al. 2003) and response inhibition (Hinkin et al. 1999; Tozzi et al. 1999) . Deficits in complex problem solving and abstraction have been demonstrated using the Wisconsin Card Sorting Test and Tower of London-Drexel Version neurocognitive assessment (Cattie et al. 2012; Cherner et al. 2004) . Furthermore, HIV-1 seropositive individuals display a greater impulsivity than control individuals on the Iowa Gambling Test (Hardy et al. 2006; Martin et al. 2004 ).
The HIV-1 transgenic (Tg) rat, which expresses 7 of the 9 HIV-1 genes, has been used in preclinical studies to model neurocognitive deficits prominent in HAND and commonly observed in HIV-1 seropositive individuals (Moran et al. 2013a (Moran et al. , b, 2014a . Specifically, adult HIV-1 Tg rats exhibit significant deficits in executive functions, including attention, inhibition, and flexibility in comparison to controls (Moran et al. 2014a) . Furthermore, significant alterations in temporal processing, a pre-attentive process, have been observed using cross-modal prepulse inhibition (PPI) of the auditory startle response (ASR) in the HIV-1 Tg rat (Moran et al. 2013a ). On both visual and auditory prepulse trials, HIV-1 Tg rats exhibited an insensitivity to ISI duration and a lack of perceptual sharpening after the adolescent period of development (Moran et al. 2013a ). There remains a critical need for longitudinal studies to understand the effect of pediatric HIV-1 infection on developmental processes (Cohen et al. 2016; Crowell et al. 2014) .
Due to high rates of chronic neurocognitive deficits in both HIV-1 seropositive children and adults, there remains a basic need for accurate screening tools for the diagnosis of HAND. Early in the HIV-1 epidemic, two screening tools, the HIV Dementia Scale (HDS; Power et al. 1995) and the International HDS (IHDS; Sacktor et al. 2005) , were developed to screen for HAD. However, neither the HDS or the IHDS are able to accurately screen for milder forms of neurocognitive impairment, which are more common in the post-cART era, affecting up to 40 %-70 % of HIV-1 infected individuals (Heaton et al. 2010 (Heaton et al. , 2011 Letendre et al. 2009; McArthur et al. 2010; Sacktor et al. 2005; Zipursky et al. 2013 ). Development of a screening tool, specifically for neurological impairment seen in PHIV has the potential for great clinical significance and may have a significant impact on the lives of HIV-1 seropositive children and adults (Zipursky et al. 2013) .
Thus, the aims of the current study were twofold. First, to establish the early trajectory of developmental deficits in the HIV-1 Tg rat. The HIV-1 Tg rat, which expresses 7 of the 9 HIV-1 genes constitutively throughout development, provides a useful model for investigating the development of neurologic impairments in pediatric AIDS (review, Fitting et al. 2015; Peng et al. 2010; Royal et al. 2012; review, Vigorito et al. 2015) . Developmental assessments, including locomotor activity, cross-modal PPI, and gap-PPI were conducted prior to weaning from postnatal day (PD) 12 to PD 21. It was hypothesized that HIV-1 Tg rats would exhibit early selective alterations in somatic growth, including body weight and eye opening, and alterations in locomotor activity, as well as preattentive processes, indexed by cross-modal PPI and gap-PPI, compared to non-transgenic F344/N controls. Second, to evaluate the potential diagnostic utility of early developmental alterations. It was hypothesized that early selective developmental alterations in the HIV-1 Tg rat would be sufficiently discriminatory and robust to support their use as a point-ofcare screening tool for chronic neurological impairment in PHIV. Understanding the early trajectory of developmental deficits in the HIV-1 Tg rats is vital to understanding the progression of neurocognitive deficits in children perinatally infected with HIV-1 and may provide an innovative point-ofcare screening tool.
Methods

Animals
Developmental assessments were conducted on Fischer (F344/N; Harlan Laboratories Inc., Indianapolis, IN) rats (HIV-1 Tg, n = 19 litters; control, n = 16 litters) prior to weaning, beginning at PD 12. All rats were tested for motor movement, assessed using locomotor activity (PD 12, 16, 20) and temporal processing deficits, assessed using cross-modal prepulse inhibition (PPI) of the auditory startle response (PD 14, 17, and 21) . Gap-PPI, which also assesses temporal processing deficits, was conducted on PD 18.
Animals were delivered to the facility between PD 7 and PD 9 over the course of one year. All animals were housed with their biological dam until PD 21 when animals were weaned and separated by sex. Subsequently animals were pair-or group-housed with animals of the same sex. Rodent food (Pro-Lab Rat, Mouse, Hamster Chow #3000) and water were provided ad libitum throughout experimentation.
Animals were maintained according to the National Institute of Health (NIH) guidelines in AAALAC-accredited facilities. The targeted environmental conditions for the animal facility were 21°± 2°C, 50 % ± 10 % relative humidity and a 12-h light:12-h dark cycle with lights on at 0700 h (EST). The Institutional Animal Care and Use Committee (IACUC) of the University of South Carolina approved the project protocol as consistent with federal assurance (# A3049-01).
Somatic growth
Body weight
Body weight was assessed as a measure of somatic growth upon arrival at the facility between PD 8 and PD 10. Body weight was assessed periodically throughout early development.
Eye opening
Eye opening was assessed as a developmental milestone from PD 13 to PD 19. Eye opening was assessed separately for the right and left eye. A scale ranging from zero to two was used with a zero score indicating a closed eye, and a score of one indicating an open eye.
Motor development
Apparatus
Square (40 × 40 cm) (Hamilton Kinder, San Diego Instruments, San Diego, CA) activity monitors were used to assess locomotor activity. Clear perspex inserts were added to convert the chambers into a round (~40 cm diameter) compartment. Free movement of animals was detected by infrared photocell (32 emitter/detector pairs) interruptions; the sensitivity of the photocells was tuned to work with the additional layer of perspex. Total locomotor activity was measured by assessing the number of photocell interruptions within a 60-min period.
Locomotor activity
Locomotor activity testing occurred on PD 12, 16, and 20. Testing occurred for a 60-min period between 700 and 1200 h (EST) under dim light conditions, in the absence of direct overhead lighting (<10 lx). All activity monitors were located in an isolated room.
Temporal processing
PPI assessments in the present study employed the classic approach popularized by Ison and Hammond (1971) . Specifically, the classic approach manipulates the interstimulus interval (ISI), the fundamental factor that operationally defines PPI. Thus, the present studies employed a range of ISI values to accurately assess the response amplitude curves for PPI.
Apparatus
The startle platform (SR-Lab Startle Reflex System, San Diego Instruments, Inc., San Diego, CA) was enclosed in a 10 cm-thick double-walled, 81 × 81 × 116-cm isolation cabinet (external dimensions) (Industrial Acoustic Company, INC., Bronx, NY), instead of the 1.9 cm thick ABS plastic or laminate cabinets offered with this system. Sound attenuation of 30 dB(A) was provided in the isolation chamber relative to the external environment. An ambient sound level of 22 dB (A) was presented in the chamber without any stimuli presented. The high-frequency loudspeaker of the SR-Lab system (model#40-1278B, Radio Shack, Fort Worth, TX), mounted inside the chamber 30 cm above the Plexiglas animal test cylinder, delivered all auditory stimuli (frequency range of 5 k-16 k Hz). A white LED light mounted on the wall in front of the test cylinder inside the chamber (22 lx; Light meter model #840006, Sper Scientific, Ltd., Scottsdale, AZ) was presented as the visual prepulse. The animal's response to the auditory stimulus produced deflection of the test cylinder, which was converted into analog signals by a piezoelectric accelerometer integral to the bottom of the cylinder. The response signals were digitized (12 bit A to D) and saved to a hard disk. Response sensitivities were calibrated using a SR-LAB Startle Calibration System. Sound levels were measured and calibrated with a sound level meter (model #2203, Bruël & Kjaer, Norcross, GA) with the microphone placed inside the Plexiglas test cylinder.
Cross-modal prepulse inhibition
Both visual and auditory prepulse stimuli were used to test animals for PPI of the ASR on PD 14, 17 and 21. PPI was administered using a 30-min test session, beginning with a 5-min acclimation period in the dark with 70 dB (A) background white noise, followed by 6 pulse-only ASR trials with a fixed 10s intertrial interval (ITI). A total of 72 trials, including an equal number of visual and auditory prepulse trials, were interdigitated in a counterbalanced ABBA order of presentation. Trials had ISIs of 0, 30, 50, 100, 200, and 4000 msec and were presented in 6-trial blocks according to a Latin-square design. The 0 and 4000 msec ISI trials were control trials. The ITI was variable from 15 s to 25 s. Inside the test cylinder, the pulse stimulus intensity was 100 dB(A) (20 msec duration). The auditory prepulse was an 85 dB(A) white noise stimulus (20 msec duration); the visual prepulse of 22 lx was also of 20 msec duration. Mean peak ASR amplitude values were collected for analysis. All test sessions were conducted in the dark.
Gap-prepulse inhibition
Animals were tested for gap-PPI of the ASR on PD 18. Gap-PPI of the ASR was conducted with a preceding gap in background white-noise as a prestimulus. A 20-min test session began with a 5-min acclimation period in the dark with 70 dB(A) background white noise, followed by six pulseonly ASR trials, used for habituation, with a fixed 10s ITI. Thirty-six trials were presented using 6-trial blocks according to a Latin-square design. A 20-msec gap in white noise preceded a startle stimulus presented at ISIs of 30,50,100, 200 and 4000 msec. Two control trial types, using 0 and 4000 msec intervals, were included to provide a reference ASR within gap-PPI. The startle stimulus intensity was 100 dB(A) (20 msec duration) measured inside the test cylinder. Mean peak ASR amplitude values were collected for analysis. All test sessions were conducted in the dark.
Statistical analysis
Categorical data, including eye opening, an index of somatic growth, was analyzed using a chi-squared (χ 2 ) statistical technique. Eye opening data were assessed by individual pup. An alpha level of p ≤ 0.05 was considered significant.
Analysis of variance (ANOVA) techniques (SPSS Statistics 20, IBM Corp., Somers, NY) were used to analyze all continuous data. To account for the nested design within the ANOVA analysis, individual observations were analyzed by using litter means and standard errors (Denenberg 1984; Wears 2002) . For repeated measures factors, either orthogonal decompositions were used for those variables that classically violate compound symmetry assumptions (e.g., trials) or the Greenhouse-Geisser df correction factor was used (Greenhouse and Geisser, 1959) . Tests of simple main effects and specific linear contrasts were used, as appropriate, to evaluate age-dependent effects of the HIV-1 transgene (Winer, 1971 ). An alpha level of p ≤ 0.05 was considered significant for all statistical tests.
Locomotor activity data was analyzed using a mixed -factor ANOVA. Cumulative photocell interruptions were used for analysis, with genotype (HIV-1 Tg vs. control) as the between-subjects factor, and time and age as the withinsubjects factor.
Cross-modal PPI data were analyzed using a mixed-factor ANOVA for both prepulse modalities (auditory, visual). Mean peak ASR amplitude for the 0-4000 msec ISIs were used for analysis, with genotype (HIV-1 Tg vs. control) as the between-subjects factor, and age, ISI, and trial as the withinsubjects factors.
For gap-PPI, a mixed-factor ANOVA was performed on mean peak ASR amplitude for the 0-4000 msec ISIs, with genotype (HIV-1 Tg, n = 13 litters vs. control, n = 11 litters) as the between-subjects factor, and ISI and trial as the withinsubjects factors.
A discriminant function analysis was conducted to determine the diagnostic accuracy of early developmental alterations and to determine which observed measures were able to correctly identify animals in regard to their genotype (HIV-1 Tg vs. Control).
Results
HIV-1 Tg animals exhibit selective alterations in somatic growth
Selective alterations in somatic growth were indexed using body weight measurements and eye opening assessments. Eye opening was assessed from PD 13 to PD 19 (Fig. 1) . A χ 2 analysis revealed a statistically significant difference between eye opening in HIV-1 Tg vs. control animals [χ 2 (4) = 34.4, p ≤ 0.001]. Eye opening began on PD 15 for both HIV-1 Tg and control animals. However, HIV-1 Tg animals exhibited later eye opening, indicated by a significant rightward shift, relative to control animals. By PD 17, 66 % of Body weight measurements, obtained upon arrival (PD 8 to PD 10), were used to assess initial somatic growth. Upon arrival, there was no significant difference in body weight between control (M = 11.9 g, SEM = 0.7 g) and HIV-1 Tg animals (M = 12.5 g, SEM = 0.6 g). Presence of the HIV-1 transgene had no significant effect on growth through PD 21 [F(2,13) < 1.0].
HIV-1 Tg animals exhibited a shift in the development of locomotor activity implicating alterations in the maturation of the forebrain cholinergic inhibitory system Alterations in locomotor activity in the HIV-1 Tg rat, relative to control animals, were evidenced using cumulative frequency of gross motor movements, illustrated in Fig. 2a, 2b , and 2c. The overall ANOVA for cumulative frequencies of locomotor activity revealed a significant age x time x genotype interaction [F(22,726) Alterations in the development of locomotor activity are further evidenced by mean total ambulation, illustrated in Fig. 3 . A segmented first-order polynomial was the best fit for the total ambulation in HIV-1 Tg animals, with maximal spontaneous activity exhibited on PD 20. In contrast, a second-order polynomial was the best fit for control animals, with maximal spontaneous activity exhibited on PD 16. Therefore, HIV-1 Tg animals fail to exhibit decreased levels of spontaneous activity, shown using cumulative frequencies and total ambulation, suggesting an alteration in the development of the forebrain cholinergic inhibitory system.
HIV-1 Tg animals exhibit altered temporal processing development with a visual prepulse
Altered development of PPI with a visual prepulse in the HIV-1 Tg rat, relative to control animals, is illustrated in Fig. 4a HIV-1 Tg animals exhibit altered temporal processing development with an auditory prepulse HIV-1 Tg animals exhibit alterations in the development of PPI with an auditory prepulse, as illustrated in Fig. 5a and 5b. The overall ANOVA on mean peak ASR amplitude revealed a significant age x ISI x genotype interaction [F(10,330 HIV-1 Tg and control animals both exhibit significant gap-PPI Both HIV-1 Tg and control animals exhibit significant inhibition with gap-PPI, illustrated in Fig. 6 . The overall ANOVA conducted on mean peak ASR amplitude for gap-PPI revealed that there was no genotype x ISI interaction. A significant main effect of genotype [F(1,22) = 4.7, p ≤ 0.05, η p 2 = 0.18] and ISI [F(5,110) = 9.5, p GG ≤ 0.001, η p 2 = 0.30] were observed. HIV-1 Tg and control animals exhibited comparable peak inhibition at the 30 msec ISI in gap-PPI. HIV-1 Tg animals exhibit a downward shift in the mean peak ASR amplitude curve relative to control animals, but did not exhibit a deficit in temporal processing per se in gap-PPI.
Early developmental alterations can accurately diagnose the presence of the HIV-1 transgene
The diagnostic utility of early developmental alterations in the HIV-1 Tg rat was further analyzed using a discriminant function analysis to determine which assessments and ages were best able to identify group membership. Assessment of crossmodal PPI on PD 17 and 21 best predicted group membership, as illustrated in Fig. 7 . The discriminant function analysis selected six variables (Auditory Mean Peak ASR Amplitude Values at 50 msec (PD 21) and 100 msec (PD 21) and Visual Mean Peak ASR Amplitude Values at 30 msec (PD 17), 100 msec (PD 17), 200 msec (PD 17) and 50 msec (PD 21)) that maximally separated the HIV-1 Tg and control animals (canonical correlation of 0.91). Animals were classified (jackknifed) with 97.1 % accuracy (F approximation of Wilks' λ of 0.176, F (6,28) =21.9, p ≤ 0.001). Discussion HIV-1 Tg rats exhibited prominent early selective developmental alterations in multiple experimental paradigms, including somatic growth, locomotor activity, cross-modal PPI, and gap-PPI. Later eye opening was observed in the HIV-1 Tg animals relative to controls. HIV-1 Tg animals failed to exhibit decreased levels of spontaneous activity on PD 20, assessed using locomotor activity, suggesting delayed maturation of the forebrain cholinergic inhibitory system. Alterations in the development of PPI and perceptual sharpening were observed in both auditory and visual PPI as indexed by a relative insensitivity to the dimension of time (msec for ISI; days of age for perceptual sharpening) as a function of the HIV-1 transgene. Presence of the HIV-1 transgene was diagnosed with 97.1 % accuracy using auditory and visual PPI on PD 17 and 21. These early selective developmental alterations observed in the HIV-1 Tg rat resemble alterations observed in PHIV, providing an innovative opportunity to develop a point-of-care screening tool for the early diagnosis of chronic neurocognitive impairment observed in PHIV.
Selective alterations in somatic growth are observed in the HIV-1 Tg rat, assessed using body weight and eye opening. No statistical differences were observed in initial body weight, assessed from PD 8 to PD 10, results which are consistent with those previously reported in male Sprague-Dawley rats stereotaxically injected with Tat and/or gp120, HIV-1 viral proteins, on PD 1 (Fitting et al. 2008 ) and in HIV-1 infected children (Guillen et al. 2007; Parachure et al. 2015) . HIV-1 Tg animals exhibited later eye opening, indicating an early selective alteration in somatic growth. Results of alterations in eye opening extend those previously reported in male Sprague-Dawley rats stereotaxically injected with HIV-1 viral proteins (Moran et al. 2014b) .
HIV-1 Tg rats exhibit alterations in the development of motor movement, assessed using locomotor activity. Significant differences in the cumulative frequency of gross motor movement were evident at PD 12 and PD 20, but not at PD 16, providing evidence for alterations in the development of motor movement. Evidence for alterations in the development of the cholinergic system were suggested using total ambulation in locomotor activity. A second-order polynomial was best fit for the time course for control animals, with maximal spontaneous activity exhibited on PD 16. In contrast, a segmented first-order polynomial was the best fit for HIV-1 Tg animals, with maximal spontaneous activity exhibited on PD 20. Results of alterations in the development of motor movement in the present study extend those previously reported in adult HIV-1 Tg rat (Moran et al. 2013b ), SpragueDawley rats stereotaxically injected with the HIV-1 viral proteins (Fitting et al. 2008) , as well as in HIV-1 infected children (Ferguson and Jelsma, 2009; Foster et al. 2006; Whitehead et al. 2014 ).
Delayed maturationof the forebrain cholinergic inhibitory system may underlie the alterations in the development of motor movement observed in HIV-1 Tg rats. Preclinical studies have well-established the nonmonotonic development of motor activity with significant increases in spontaneous activity from PD 10 to PD 15, maximal spontaneous activity exhibited on PD 16, followed by significant decreases from PD 17 to PD 25 (Campbell et al. 1969; Campbell and Mabry 1972; Moorcroft et al. 1971) . Pharmacological assessments provided evidence for the relationship between the maturation of the cholinergicinhibitory system and measurements of spontaneous activity (Campbell et al. 1969; Fibiger et al. 1970) . Injections of scopolamine hydrobromide, a muscarinic antagonist, significantly increased motor movement in animals at PD 20, but had no effect on motor movement at PD 10 and PD 15 (Campbell et al. 1969) . Additionally, injections of both scopolamine hydrobromide and amphetamine produced hyperactivity in rats at PD 25, but not at PD 15, providing additional evidence for the maturation of the forebrain cholinergic inhibitory system from PD 15 to PD 25 (Fibiger et al. 1970) . Thus, the decline in motor movement, observed following maximal spontaneous activity on PD 16, may be modulated, at least in part, by the maturational status of the cholinergic system.
Alterations in the development of PPI, assessed using both auditory and visual prepulses, was observed in HIV-1 Tg animals compared to control animals. In PPI with a visual prepulse, the ISI functions observed in the HIV-1 Tg and control groups were not significantly different at PD 14, but subsequently changed in different ways (i.e., PD 17 and PD 21). HIV-1 Tg animals, in comparison to controls, therefore, exhibit alterations in the development of PPI and perceptual sharpening in PPI with a visual prepulse. HIV-1 Tg animals also exhibited an alteration in the development of PPI and perceptual sharpening, indexed by a relative insensitivity to the manipulation of time, in PPI with an auditory prepulse, in comparison to control animals. Results in the present study extend those previously reported in adult HIV-1 Tg animals (Moran et al. 2013a ), Sprague-Dawley rats stereotaxically injected with the HIV-1 viral proteins on PD 1 (Fitting et al. 2008 (Fitting et al. , 2006a , and HIV-1 seropositive adults meeting criteria for HAND (Minassian et al. 2013) .
HIV-1 Tg and control animals exhibited significant inhibition in gap-PPI. Comparable peak inhibition at the 30 msec ISI was observed in both HIV-1 and control animals. A downward shift in the mean peak ASR amplitude curve was observed in HIV-1 Tg animals, however, a deficit in temporal processing per se was not observed in gap-PPI. Gap-PPI results in the present study foreshadow those of a preliminary longitudinal analysis conducted from PD 30 to PD 180 (McLaurin et al. 2016) . Specifically, preliminary gap-PPI analyses suggest alterations in the development of temporal processing, assessed using the auditory startle response and prepulse inhibition, beginning at PD 60 (McLaurin et al. 2016) .
Early selective developmental alterations observed in the HIV-1 Tg rat may provide a novel point-of-care screening tool for the diagnosis of neurocognitive deficits in children perinatally infected with HIV-1. The potential utility of early selective developmental alterations was assessed using a discriminant function analysis, which correctly identified animals in regards to their genotype (HIV-1 Tg vs. control) with 97.1 % accuracy. The presence of the HIV-1 transgene was best predicted using cross-modal PPI assessments at PD 17 and PD 21; an age at which the maturation of fundamental brain development processes (e.g., synaptogenesis) are comparable to 1-3 years of age in humans (review, Semple et al. 2013) .
The eyeblink startle paradigm, which measures the eyeblink component of the ASR using electromyography (EMG), provides a clinically relevant experimental paradigm for the assessment of prepulse inhibition in humans. Gap-PPI, assessed using the eyeblink startle paradigm, has been used to assess tinnitus deficits in humans, also providing critical information regarding the underlying neural circuitry (Fournier and Hebert 2013) . The eyeblink startle paradigm has also been used to assess the effects of prenatal cocaine exposure (Anday et al. 1989 ) and chronic cocaine use (Corcoran et al. 2011; Efferen et al., 2000) . Most notably, alterations in temporal processing have been observed in HIV-1 seropositive individuals with HAND using the eyeblink startle paradigm (Minassian et al., 2013) . The eyeblink startle paradigm, therefore, appears to be a clinically relevant experimental paradigm for assessing temporal processing. Thus, the present study, suggests the potential clinical utility of the eyeblink startle paradigm as a point-of-care screening tool for pediatric HIV-1.
Significant evidence has been provided for alterations in the development of the dopamine (DA) system which may also underlie early selective developmental alterations observed in the HIV-1 Tg rat (review, Fitting et al. 2015) . Preclinical studies in the HIV-1 Tg rat have previously implicated DA system impairments as an underlying factor in chronic neurological impairment in HIV-1 infected children (Lee et al. 2014; Moran et al. 2012 Moran et al. , 2014b Webb et al. 2010) . Specifically, pharmacological assessments were used to examine alterations in the midbrain dopaminergic system in the HIV-1 Tg rat (Moran et al. 2012; Webb et al. 2010) . Dopaminergic system dysfunction, assessed using Western blotting, was evidenced by alterations in phosphorylated tyrosine hydroxylase (pTH), dopamine transporter (DAT) mRNA, and/or monoamine oxidase A (MAO-A; Moran et al. 2012; Webb et al. 2010 ). In addition, young HIV-1 Tg rats exhibit deficits in D 2 / 3 receptors in the dorsal striatum, assessed using [
18 F]fallypride positron emission tomography (PET) (Lee et al. 2014) .
The DA system may be a clinically relevant target for the treatment of chronic neurological impairments observed in children perinatally infected with HIV-1. Treatment with levodopa, a DA agonist, consistently improved motor function deficits observed in children with pediatric HIV-1 (Mintz et al. 1996) . Additionally, methylphenidate, which inhibits DA reuptake, has been implicated as a potential therapeutic treatment for HIV-1 seropositive adults with cognitive slowing (Hinkin et al. 2001) . Although multiple neural systems may mediate the early developmental alterations observed in the HIV-1 Tg rat, HIV-1 infection often affects development of dopaminergic system function, evidenced in preclinical and clinical studies, and associated with subsequent cognitive deficits (review, Fitting et al. 2015) . Thus, the DA system may serve as a key target for therapeutic intervention in children perinatally infected with HIV-1.
To date, a full understanding of the neuropathogeneis of pediatric HIV-1 has not been elucidated (Linn et al. 2015) . The current literature, however, suggests striking differences in the neuropathogeneis of pediatric HIV-1, in comparison to HIV-1 seropositive adults, which may have significant implications for the development of chronic neurological impairment. Post-mortem studies of HIV-1 infected children prior to the advent of cART observed infection of neural progenitor cells, which are critical for the growth and development of neurons (Schwartz et al. 2007 ). HIV-1 infection has also been observed in macrophages, microglial cells, and a small number of neurons in brain tissue of children perinatally infected with HIV-1 (Cantó-Nogués et al., 2005) . Oxidative stress (i.e., Aksenov et al. 2006 Aksenov et al. , 2001 , neuroinflammation (i.e., Gao et al. 2008; Tansey and Goldberg 2010) , and synaptodendritic injury (i.e., Ellis et al. 2007; Gelman and Nguyen 2010) are other potential mechanisms contributing to neurocognitive impairment in the HIV-1 Tg rat. Specifically, chronic immune activation has been previously observed in the brains of the HIV-1 Tg rat (Rao et al. 2011; Royal et al. 2012) . Synaptodendritic alterations, including decreased dendritic branching complexity and shifts in dendritic spine parameters have also been observed in the HIV-1 Tg rat (Rao et al. 2011; Roscoe et al. 2014) . Accordingly, the neurotoxic effects of HIV-1 viral proteins, present in the HIV-1 Tg rat, may have a significant effect on the developing brain via a variety of mechanisms (Crowell et al. 2014) .
The study of early selective developmental alterations in the HIV-1 Tg rat is vital to the development of a point-of-care screening tool for chronic neurologic impairment observed in children perinatally infected with HIV-1 (review, Luzuriaga and Mofenson, 2016) . HIV-1 Tg rats used in the present study are a healthier derivation of those originally described (Reid et al. 2001) , exhibiting no general wasting or pathological phenotypes. HIV-1 Tg litters used in the current study displayed no significant health disparities in comparison to F344 controls (i.e., similar initial body weight, similar litter size). Despite the absence of viral replication, chronic, immune activation has been observed in the brains of HIV-1 Tg rats (Rao et al. 2011; Royal et al. 2012) , suggesting the presence of a mild, neuroinflammatory microenvironment.
Thus, the HIV-1 Tg rat provides a vehicle for investigating the development and underlying mechanisms involved in chronic neurologic impairments observed in PHIV (review, Vigorito et al. 2015) .
HIV-1 Tg rats exhibited early selective developmental alterations, including somatic growth, motor development, and prepulse inhi bi tion. St riking differences in the neuropathogenesis of pediatric HIV-1, in comparison to HIV-1 seropositive adults, have been observed; differences which may have significant implications for the development of chronic neurological impairment observed in the present study. Most notably, early selective developmental alterations observed in the HIV-1 Tg rats heralds an opportunity for the development of a point-of-care screening tool, which will allow for early diagnosis of PHIV and therapeutic initiation, improving long-term outcomes for children perinatally infected with HIV-1 (Edwards et al. 2015; Kitahata et al. 2009; review, Luzuriaga and Mofenson, 2016) .
